This is consistent with the finding that even TNF-α (NF-κB inducer)-primed colon carcinoma HCT116 cells failed to protect constitutive NF-κB activation, in response to TAT-FADD treatment. The gene discussed is NFKB1; the disease is colon carcinoma.